Furukawa Shigenori, Soeda Shu, Endo Hisahito, Yoshimoto Yuki, Kato Asami, Okabe Chikako, Miura Hideki, Sato Tetsu, Kamo Norihito, Endo Yuta, Yamaguchi Hisashi, Takagawa Yoshiaki, Ohara Yoshihiro, Sano Hideki, Kiko Yuichiro, Hojo Hiroshi, Hashimoto Yuko, Fujimori Keiya
Department of Regional Gynecologic Oncology, Fukushima Medical University, Fukushima, Japan;
Department of Gynecology, Southern Tohoku General Hospital, Koriyama, Japan.
Anticancer Res. 2025 Sep;45(9):4027-4035. doi: 10.21873/anticanres.17760.
BACKGROUND/AIM: Primary uterine Ewing's Sarcoma is an extremely rare and aggressive tumor. Due to its rarity, there is no established standard treatment, and most cases involve radical surgery, often compromising fertility and ovarian function. Recent advances in multimodal therapy have introduced fertility-preserving approaches for young patients.
An 18-year-old woman visited our hospital for a detailed examination of a 10 cm-sized uterine tumor initially diagnosed as a leiomyoma by MRI. A GnRH agonist was administered to treat presumed myoma and associated anemia. Despite the administration of three cycles of the GnRH agonist, the patient's anemia did not improve. The size of the tumor was not reduced, and the inner structure of the tumor became irregular. A tumorectomy was performed and the uterus was repaired. Histological examination, including immunohistochemical staining, suggested Ewing's Sarcoma based on hematoxylin-eosin findings and strong CD99 positivity. Fluorescence in situ hybridization confirmed ESWR1 gene rearrangement in the tumor cells, leading to a definitive diagnosis of Ewing's Sarcoma. Since PET-CT showed pelvic and para-aortic lymph metastasis after laparotomy, VDC-IE chemotherapy was performed after oocyte cryopreservation. The multiple swellings of the lymph nodes were improved. To enhance curative potential, proton therapy was administered to the whole pelvis and para-aortic lymph nodes. To preserve ovarian function, a laparoscopic ovarian transposition was performed before proton therapy. Her right ovary was mobilized to the peritoneum at the level of the upper lobe of the right kidney a retroperitoneal tunnel. 54-Gy proton therapy was performed, and complete response was obtained.
This case of primary uterine Ewing's Sarcoma was treated with multimodal therapy, achieving curative outcome while preserving ovarian function and fertility through laparoscopic ovarian transposition.
背景/目的:原发性子宫尤因肉瘤是一种极其罕见且侵袭性强的肿瘤。由于其罕见性,尚无既定的标准治疗方法,大多数病例采用根治性手术,这常常会损害生育能力和卵巢功能。多模式治疗的最新进展为年轻患者引入了保留生育功能的方法。
一名18岁女性因对一个最初经磁共振成像(MRI)诊断为平滑肌瘤的10厘米大小子宫肿瘤进行详细检查而就诊于我院。给予促性腺激素释放激素(GnRH)激动剂治疗推测的肌瘤及相关贫血。尽管给予了三个周期的GnRH激动剂,但患者的贫血并未改善。肿瘤大小未缩小,且肿瘤内部结构变得不规则。进行了肿瘤切除术并修复了子宫。包括免疫组织化学染色在内的组织学检查,根据苏木精-伊红染色结果和强烈的CD99阳性提示为尤因肉瘤。荧光原位杂交证实肿瘤细胞中存在ESWR1基因重排,从而明确诊断为尤因肉瘤。由于剖腹手术后正电子发射断层扫描(PET-CT)显示盆腔和腹主动脉旁淋巴结转移,在卵母细胞冷冻保存后进行了VDC-IE化疗。淋巴结的多处肿大得到改善。为提高治愈潜力,对整个盆腔和腹主动脉旁淋巴结进行了质子治疗。为保留卵巢功能,在质子治疗前进行了腹腔镜卵巢移位术。将其右卵巢经腹膜后隧道移位至右肾上极水平的腹膜处。进行了54 Gy的质子治疗,并获得了完全缓解。
该例原发性子宫尤因肉瘤采用多模式治疗,通过腹腔镜卵巢移位术在保留卵巢功能和生育能力的同时取得了治愈效果。